United States · FDA National Drug Code directory

Non-Drowsy Allergy Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
11673-621_d7eb1caf-eeff-10b7-c464-3592c8d7d0ee
Product NDC
11673-621
Form
TABLET
Composition / generic term
Fexofenadine hydrochloride
Labeler
TARGET CORPORATION
Marketing category
ANDA
Marketing start / end (source format)
20250801
Source listing expiry
20261231

Source-listed ingredients

  • FEXOFENADINE HYDROCHLORIDE — 180 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (11673-621-01) / 150 TABLET in 1 BOTTLE · 11673-621-01
  • 3 BLISTER PACK in 1 CARTON (11673-621-15) / 5 TABLET in 1 BLISTER PACK · 11673-621-15
  • 1 BOTTLE in 1 CARTON (11673-621-30) / 30 TABLET in 1 BOTTLE · 11673-621-30
  • 150 TABLET in 1 BOTTLE (11673-621-50) · 11673-621-50
  • 1 BOTTLE in 1 CARTON (11673-621-70) / 70 TABLET in 1 BOTTLE · 11673-621-70

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →